Failure of High-Dose Daptomycin for Bacteremia Caused by Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions
Cargando...
Fecha
2014
Título de la revista
Publicado en
Clinical Infectious Diseases, 1058-4838, Vol. 59, Nro. 9, 2014, p. 1277–1280
Publicado por
Oxford University Press
URL de la fuente
Enlace a contenidos multimedia
ISSN de la revista
Título del volumen
Resumen
Descripción
Abstract
High-dose daptomycin (DAP) therapy failed in a neutropenic patient with bloodstream infection caused by a DAP-susceptible Enterococcus faecium (minimum inhibitory concentration, 3 μg/mL) harboring genetic changes associated with DAP resistance, with persistent bacteremia and selection of additional resistances. Daptomycin monotherapy should be used cautiously against DAP-susceptible E. faecium strains with minimum inhibitory concentrations >2 μg/mL.
Palabras clave
Keywords
Daptomycin, Enterococcus faecium, Resistance, Treatment failure
Temáticas
Daptomicina
Enterococcus faecium
Tratamientos
Enterococcus faecium
Tratamientos